Company Valuation: COSMOS Pharmaceutical Corporation

Data adjusted to current consolidation scope
Fiscal Period: May 2022 2023 2024 2025 2026 2027 2028 2029
Market Cap 1 483,107 525,081 502,890 700,001 476,495 504,948 - -
Change - 8.69% -4.23% 39.2% -31.93% 5.97% - -
Enterprise Value (EV) 1 450,132 497,354 477,918 692,920 476,495 532,781 540,892 548,173
Change - 10.49% -3.91% 44.99% -31.23% 11.81% 1.52% 1.35%
P/E 20.9x 22.1x 20.6x 22.6x 14.9x 15.8x 15x 14.2x
PBR 2.54x 2.49x 2.17x 2.72x 1.68x 1.64x 1.51x 1.39x
PEG - 7.98x 7.61x 0.8x 4.32x -56.28x 2.7x 2.7x
Capitalization / Revenue 0.64x 0.63x 0.52x 0.69x 0.43x 0.43x 0.4x 0.37x
EV / Revenue 0.6x 0.6x 0.5x 0.69x 0.43x 0.46x 0.43x 0.41x
EV / EBITDA 10x 10.5x 9.29x 11.1x 7.12x 7.54x 7.17x 6.85x
EV / EBIT 15.1x 16.5x 15.2x 17.1x 11.3x 12x 11.6x 11.1x
EV / FCF -39.1x 93.5x -222x -807x -20.6x -79.5x -111x -609x
FCF Yield -2.56% 1.07% -0.45% -0.12% -4.85% -1.26% -0.9% -0.16%
Dividend per Share 2 40 50 60 70 82 85.3 90.01 94.2
Rate of return 0.66% 0.75% 0.95% 0.79% 1.36% 1.34% 1.41% 1.48%
EPS 2 292.4 300.5 308.6 390.9 404.3 403.2 425.6 448
Distribution rate 13.7% 16.6% 19.4% 17.9% 20.3% 21.2% 21.2% 21%
Net sales 1 755,414 827,697 964,989 1,011,390 1,099,583 1,169,035 1,252,854 1,346,732
EBITDA 1 44,906 47,496 51,425 62,633 66,929 70,661 75,423 79,995
EBIT 1 29,796 30,128 31,501 40,404 42,353 44,227 46,702 49,285
Net income 1 23,155 23,797 24,454 30,978 32,046 31,963 33,733 35,499
Net Debt 1 -32,975 -27,727 -24,972 -7,081 - 27,833 35,944 43,225
Reference price 2 6,100.00 6,630.00 6,345.00 8,832.00 6,012.00 6,371.00 6,371.00 6,371.00
Nbr of stocks (in thousands) 79,198 79,198 79,258 79,257 79,257 79,257 - -
Announcement Date 11/7/22 10/7/23 12/7/24 11/7/25 13/7/26 - - -
1JPY in Million2JPY
Estimates

P/E, Detailed evolution



P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
15.8x0.46x7.54x1.34% 3.17B
16.01x0.63x9.49x-.--% 14.17B
19.15x0.88x8.94x1.98% 7.32B
23.15x0.4x6.18x1.95% 7.04B
18.85x0.67x11.61x1.54% 5.63B
17.15x1.07x7.65x2.63% 4.84B
16.52x0.73x7.78x2.45% 4.21B
15.58x0.69x5.7x4.58% 3.54B
18.52x0.39x6.15x1.24% 3.29B
14.95x1.26x7.99x5.88% 3.3B
Average 17.57x 0.72x 7.90x 2.36% 6B
Weighted average by Cap. 17.77x 0.70x 8.30x 1.84%

Y-o-Y evolution of P/E

Valuation ratios - P/E - COSMOS Pharmaceutical Corporation

Historical PBR trend

Valuation ratios - PBR - COSMOS Pharmaceutical Corporation

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - COSMOS Pharmaceutical Corporation

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - COSMOS Pharmaceutical Corporation


Year-on-year evolution of the Yield

Valuation ratios - Yield - COSMOS Pharmaceutical Corporation
  1. Stock Market
  2. Stocks
  3. 3349 Stock
  4. Valuation COSMOS Pharmaceutical Corporation